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Abstract: 
Adipose tissue (AT) expansion is accompanied by the infiltration and accumulation of AT 
macrophages (ATMs), as well as a shift in ATM polarization. Several studies have implicated 
recruited M1 ATMs in the metabolic consequences of obesity; however, little is known regarding 
the role of alternatively activated resident M2 ATMs in AT homeostasis or how their function is 
altered in obesity. Herein, we report the discovery of a population of alternatively activated 
ATMs with elevated cellular iron content and an iron-recycling gene expression profile. These 
iron-rich ATMs are referred to as MFehi, and the remaining ATMs are referred to as MFelo. In 
lean mice, ~25% of the ATMs are MFehi; this percentage decreases in obesity owing to the 
recruitment of MFelo macrophages. Similar to MFelo cells, MFehi ATMs undergo an 
inflammatory shift in obesity. In vivo, obesity reduces the iron content of MFehi ATMs and the 
gene expression of iron importers as well as the iron exporter, ferroportin, suggesting an 
impaired ability to handle iron. In vitro, exposure of primary peritoneal macrophages to saturated 
fatty acids also alters iron metabolism gene expression. Finally, the impaired MFehi iron handling 
coincides with adipocyte iron overload in obese mice. In conclusion, in obesity, iron distribution 
is altered both at the cellular and tissue levels, with AT playing a predominant role in this 
change. An increased availability of fatty acids during obesity may contribute to the observed 
changes in MFehi ATM phenotype and their reduced capacity to handle iron. 
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Introduction 
Obesity is marked by the preferential accumulation of inflammatory M1 adipose tissue (AT) 
macrophages (ATMs), which play an important role in the development of AT inflammation and 
insulin resistance (IR) (1). The onset of AT dysfunction has important implications systemically, 
as AT inflammation and dysregulated lipolysis both promote ectopic lipid deposition and the 
accompanying metabolic consequences (2). Not surprisingly, a vast majority of the current 
literature is focused on mechanisms contributing to the recruitment and M1 polarization of 
infiltrating ATMs. Unfortunately, there remains a paucity of information regarding the 
physiological role of resident M2 polarized ATMs, as well as the manner by which resident 
ATM function is compromised in obesity. This represents an important gap in our current 
understanding of AT physiology, as defining the contribution of resident ATMs to AT 
homeostasis is a crucial step toward identifying the mechanisms underlying AT dysfunction in 
obesity. 
Recently, the area of AT iron metabolism has received increasing attention. Adipogenesis, which 
is associated with the upregulation of various genes involved in iron metabolism (3), is induced 
by heme-iron through a REV-ERBα–mediated pathway (4,5). Interestingly, whereas iron overload 
induces adipocyte IR (6,7), strategies to reduce systemic iron concentrations (e.g., low-iron diet, 
chelation therapy, and phlebotomy) improve insulin sensitivity in obese animal models (8–10) and 
humans (6,11–13). The aforementioned evidence, combined with the fact that macrophages, as part 
of the reticuloendothelial system, play the predominant role in systemic iron recycling (14), raises 
the possibility that ATM iron handling contributes to AT homeostasis. 
In the context of iron metabolism, macrophages are most commonly associated with their role in 
iron recycling for the purpose of providing an adequate supply of iron to support erythropoiesis, 
as well as to sequester iron as a bacteriostatic measure in response to acute infection (14). Recent 
data demonstrating that in vitro polarization dictates macrophage iron handling (15,16), combined 
with the increased M1 polarization observed in obesity, prompted us to explore the potential for 
ATMs to handle iron. Herein, we report the discovery of a population of alternatively activated 
resident ATMs that are natively ferromagnetic due to an elevated intracellular iron pool and 
display an iron-recycling gene expression profile. Additionally, we describe the influence of 
high-fat feeding on ATM iron handling and provide evidence for a systemic redistribution of 
tissue iron stores in obesity. 
Research Design and Methods 
Mice and Diets 
Animal care and experimental procedures were performed in accordance with and approval by 
the Vanderbilt University Institutional Animal Care and Use Committee. Male C57BL/6J wild-
type (WT) mice were purchased from The Jackson Laboratory (Bar Harbor, ME). At 8 weeks of 
age, mice were kept on a normal chow diet (NCD) or placed on low-fat (LFD) (10% kcal from 
fat, cat. no. D12450B; Research Diets) or high-fat (HFD) (60% kcal from fat, cat. no. D12492; 
Research Diets) diets for 16 weeks. The LFD and HFD both contain 10 g mineral mix (cat. no. 
S10026; Research Diets) per 4,000 kcal digestible energy, with each 10 g mineral mix providing 
37 mg iron. Mice had free access to food and water throughout the study. 
SVF Isolation 
Mice were killed via cervical dislocation and perfused with PBS. Epididymal fat pads were 
removed, and the stromal vascular fraction (SVF) and adipocytes were isolated via collagenase 
digestion and differential centrifugation as previously described (17,18). 
Magnetic Cell Sorting 
Cells of the SVF were passed through an autoMACS magnetic-activated cell-sorting system 
(Miltenyi Biotec) to isolate natively ferromagnetic ATMs. After magnetic separation, 
nonferromagnetic and ferromagnetic fractions of the SVF were centrifuged at 500g for 10 min at 
4°C and resuspended in fluorescence-activated cell sorter (FACS) buffer. 
FACS Analysis and Sorting 
The SVF was labeled with primary fluorophore-conjugated antibodies as previously described, 
and FACS analysis was performed on an LSRFortessa flow cytometer (BD Biosciences). Data 
were analyzed and figures generated using Cytobank (19). Isolation of MFehi and MFelo ATMs 
(F4/80hiCD11bhi) was performed using a FACSAria III cell sorter (BD Biosciences). The 
following antibodies, along with appropriate isotype controls, were used to characterize ATM 
populations: allophycocyanin-conjugated anti-mouse F4/80 (eBioscience), fluorescein 
isothiocyanate–conjugated anti-mouse CD11b (eBioscience), PE-conjugated anti-mouse CD206 
(R&D Systems), phycoerythrin-conjugated anti-mouse MGL1/2 (R&D Systems), phycoerythrin-
conjugated anti-mouse CD11c (eBioscience), phycoerythrin-conjugated anti-mouse CCR2 (R&D 
Systems), and CF594 (Biotium) conjugated anti-mouse CD163. 
PKH26 Studies 
Male C57BL/6 mice were placed on a 60% HFD for 6 weeks, injected with 5 μmol/L PKH26 
i.p., and maintained on HFD for an additional week. Approximately 90% of ATMs label with 
PKH26 (data not shown). At sacrifice, SVF cells were isolated and stained with 
allophycocyanin-conjugated anti-mouse F4/80 and DAPI. F4/80+PKH26+DAPI− and 
F4/80+PKH26−DAPI− macrophages were separated via FACS. Sorted cells were then further 
separated into MFelo and MFehi fractions using the Miltenyi AutoMacs sorter. Cell number in 
each fraction was determined by counting on a hemocytometer. 
Primary Peritoneal Macrophage Isolation and Fatty Acid Treatments 
Primary peritoneal macrophages (PPMs) were isolated from mice 3 days after injection with 2% 
thioglycollate. Cells were plated for 48 h followed by treatment with 500 μmol/L palmitic or 
oleic acid for 24 h as previously described (20). Cells were collected in TRIzol reagent for RNA 
isolation and real-time RT-PCR analysis. 
RNA Isolation and Real-Time RT-PCR 
RNA was isolated from liver using an RNeasy mini-kit (Qiagen) and from adipocytes and ATMs 
using TRIzol reagent (Invitrogen) according to the manufacturer’s instructions with minor 
modifications, including the use of 1-bromo-3-chloropropane (Sigma-Aldrich) and RNase-free 
glycogen (Roche Diagnostics). Additionally, RNA extracted from isolated adipocytes and ATMs 
was subjected to DNase treatment (DNA-free kit; Applied Biosystems). cDNA was synthesized 
using the iScript cDNA synthesis kit (BioRad), and real-time RT-PCR was performed on an iQ5 
cycler (BioRad) using Taqman gene expression assays (Applied Biosystems [cat. nos. available 
upon request]). Gene expression for MFehi and MFelo cells was normalized to hypoxanthine 
guanine phosphoribosyl transferase or glyceraldehyde-3-phosphate dehydrogenase using the 
2−∆∆Ct method (21). Expression for PPMs was normalized to cytochrome b. 
Tissue Iron Visualization 
Tissue iron distribution was visualized using the perfusion Perls’ Prussian blue staining method 
(22). Subsequent to perfusion with PBS supplemented with heparin (5 units/mL), mice were 
perfused with a Prussian blue staining solution containing 4% paraformaldehyde, 1% potassium 
ferrocyanide, and 1% HCl. One hour postperfusion, tissues were removed and incubated in 
staining solution for 12 h at 4°C prior to being paraffin embedded. Tissue sections were then 
cleared, hydrated, and counterstained with nuclear fast red. 
Cellular and Tissue Iron Quantification 
Ferromagnetic and nonferromagnetic ATMs were digested in ultra-pure HNO3. A double-
focusing sector field high-resolution inductively coupled plasma mass spectrometry (ICP-MS) 
(ELEMENT II; Thermo Fisher Scientific, Bremen, Germany) equipped with ESI auto sampler 
was used for the quantitative analysis of ATM iron content in the isolated cells. The elemental 
measurement was performed on isotopes 25Mg, 42Ca, 55Mn,56Fe, 59Co, 60Ni, 63Cu, and 66Zn at a 
mass resolution m/Δm 4,400 to separate molecular interferences. Elemental standards for 
external calibration were purchased from Fluka. 
Splenic, hepatic, and adipocyte iron concentrations were measured with graphite furnace atomic 
absorption spectrometry (Varian AA240; Varian). Spleen and liver samples were homogenized 
in radioimmunoprecipitation assay buffer 1:10 w/v for protein determination using the 
bicinchoninic assay (Pierce Chemicals). An aliquot of the homogenate was then digested in ultra-
pure HNO3 (1:3 v/v dilution) for 48–72 h at 60°C in a sand bath. Adipocyte pellets were 
homogenized in 100 μL radioimmunoprecipitation assay for bicinchoninic assay protein analysis, 
and aliquots were digested in 1:2 v/v ultra-pure HNO3. All digested samples were further diluted 
with a 2% nitric acid solution (1:20 to 1:100, as necessary) for analysis. Bovine liver (National 
Bureau of Standards, Standard Reference Material, United States Department of Commerce, 
Washington, DC) (184 µg Fe/g) was used as an internal standard for analysis. 
Serum Iron Parameters 
Total iron-binding capacity and serum iron, transferrin, and ferritin concentrations were 
quantified using an ACE Alera clinical chemistry system (Alfa Wasserman). Transferrin 
saturation was calculated as (serum iron/total iron-binding capacity) × 100%. 
Statistics 
All data are reported and presented in figures as means ± SEM. Two-tailed unpaired t tests were 
used to compare means between two groups, and one-way ANOVA with the Tukey correction 
for multiple comparisons was used when comparing more than two groups. Statistical analyses 
were performed using GraphPad Prism (La Jolla, CA). 
Results 
AT Contains a Population of Ferromagnetic Macrophages 
A population of iron-containing ATMs distributed interstitially throughout the AT of lean, NCD-
fed male WT mice was detected using the perfusion Perls' Prussian blue method (22) (Fig. 1A). 
This population was isolated from the SVF via magnetic column separation, yielding a 
ferromagnetic population and a nonferromagnetic population. Subsequent FACS using F4/80 and 
CD11b (Fig. 1B) demonstrated that 35% of nonferromagnetic cells were macrophages (Fig. 1C), 
compared with 90% of ferromagnetic cells. Unless otherwise indicated, subsequent experiments 
used a strategy of sequential magnetic/FACS to permit the direct comparison of viable 
ferromagnetic (MFehi) and nonferromagnetic (MFelo) ATMs. MFehi ATMs displayed a greater 
than twofold increase in cellular iron content compared with MFelo ATMs (Fig. 2A). For 
confirmation that the ferromagnetic properties of the MFehi cells were due to increased iron 
content as opposed to other ferromagnetic elements, ICP-MS was used to assess nickel and 
cobalt. In addition, copper, zinc, magnesium, calcium, and manganese were quantified 
(Supplementary Fig. 1). Only iron concentrations were significantly different between the 
MFehi and MFelocells. 
 
Figure 1. AT contains a population of ferromagnetic ATMs. A: Identification of iron-rich ATMs in 
epididymal fat pads of NCD mice (left panel, ×20, and right panel, ×40 magnification). Mice were 
perfused with Perls’ Prussian blue staining solution, and sections were counterstained with nuclear fast 
red. Iron-containing ATMs are stained blue. B: Characterization of ferromagnetic and nonferromagnetic 
fractions of the SVF from NCD mice by flow cytometry. After magnetic sorting, the proportion of viable 
ATMs (F4/80hiCD11bhi) within ferromagnetic and nonferromagnetic fractions was quantified. 
The rightmost column depicts diff-quick staining of isolated ATMs from each fraction. C: Comparison of 
ATMs as a percentage of viable cells in the nonferromagnetic and ferromagnetic fractions of the SVF 
from NCD mice (n = 13/group). ****P < 0.0001. FSC, forward scatter. 
 
Figure 2. MFehi ATMs are a subset of alternatively activated ATMs with elevated cellular iron content 
and an iron-recycling gene expression profile. A: Comparison of MFelo and MFehiATM iron content from 
NCD-fed mice. MFelo and MFehi ATMs were isolated via sequential magnetic and FACS sorting, and 
cellular iron content was quantified by ICP-MS (n = 4/group) (****P < 0.0001). Band C: Comparison of 
MFelo and MFehi ATM gene expression. MFelo and MFehi ATMs were isolated from NCD-fed mice and 
analyzed by real-time RT-PCR for the expression of genes involved in iron metabolism (B) and markers 
of M2 and M1 polarization (C) (n = 3–4/group). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. 
In addition to an elevated iron pool, MFehi ATMs exhibited a gene expression profile indicating 
a role in iron recycling (Fig. 2B). This included significantly greater expression of the genes 
involved in iron uptake (Cd163 and transferrin receptor-1 [Tfrc]), metabolism (heme oxygenase-
1 [Hmox1]), storage (ferritin light and heavy chains [Ftl1 and Fth1, respectively]), and export 
(ceruloplasmin [Cp] and ferroportin-1 [Slc40a1]) in MFehi compared with MFelo cells. The 
upregulation of transferrin receptor and CD163, the hemoglobin-scavenger receptor, implicate 
uptake of iron by MFehi cells from various sources. 
MFehi Are Alternatively Activated 
In light of recent data suggesting that M2 polarization induces an iron recycling phenotype (15), 
we sought to determine the polarization of MFehi ATMs. While all ATMs from lean AT are 
expected to be M2-like (23), the expression of M2 markers, stabilin-1 (Stab1), macrophage 
galactose-type C-type lectin 1 (MGL1 [Clec10a]), and IL-10 (Il10) were significantly increased 
in MFehi compared with MFelo ATMs. In contrast, the M1 markers, CD11c (Itgax), CCR7 
(Ccr7), and Il-1β (Il1b) were significantly reduced in MFehi cells (Fig. 2C). Flow cytometry also 
revealed that a significantly greater proportion of MFehi ATMs are CD163 and MGL1/2 positive, 
whereas a significantly reduced proportion of MFehi ATMs express the M1 markers, CD11c and 
CCR2 (Fig. 3). 
 
Figure 3. FACS analysis of MFelo and MFehi ATMs. Flow cytometry was used to measure MFelo and 
MFehi ATM expression of M2 markers (CD163 and MGL1/2) and M1 markers (CD11c and CCR2) from 
the SVF of NCD mice. The top row depicts the initial gating on viable F4/80hiCD11bhi MFelo and 
MFehiATMs. Isotype controls used to gate for M2 and M1 markers are shown in the left column. 
Therightmost column compares the number of MFelo and MFehi ATMs positive for each M2 or M1 
marker as a percent of viable F4/80hiCD11bhi ATMs (n = 3–4/group for each marker). *P < 0.05, **P < 
0.01. (A high-quality color representation of this figure is available in the online issue.) 
Obesity Induces a Shift in MFehi Polarization Toward an Inflammatory M1 Phenotype 
Next, mice were placed on an LFD or HFD for 16 weeks to determine the impact of obesity on 
the polarization and iron-handling phenotype of MFehiATMs. As anticipated, HFD feeding 
increased the absolute number of ATMs (Fig. 4A), as well as the number of ATMs relative to AT 
mass (Fig. 4B). This increase was driven by a dramatic accumulation of MFelo ATMs, whereas 
the relative number of MFehi ATMs did not change after HFD. The marked accumulation of 
MFelo ATMs resulted in a significant decrease in the number of MFehi ATMs as a percent of 
total ATMs from 27% in lean controls to 14% in obese mice (Fig. 4C). Perls’ Prussian blue 
staining of AT revealed that MFehi ATMs are predominately, but not exclusively, located 
interstitially, with a small number associated with crown-like structures within obese AT 
(Supplementary Fig. 2). In agreement with the previously demonstrated inflammatory nature of 
recruited ATMs, MFelo ATMs isolated from obese mice display decreased gene expression of 
M2 markers and increased expression of M1 markers compared with MFelo ATMs from lean 
mice (Supplementary Fig. 3A). Despite retaining an alternatively activated gene expression 
profile relative to MFelo ATMs from obese mice (Supplementary Fig. 3B), HFD-fed compared 
with LFD-fed mice had decreased MFehi ATM gene expression of the M2 
markers, Stab1 andClec10a (Fig. 4D). The MFehi ATM population also exhibited an 
inflammatory shift, as HFD feeding increased Itgax, Ccr7, Tnfα, and Il1βexpression by 
MFehi ATMs. As expected, flow cytometric analysis of MFelocells demonstrated an increased 
M1-like profile in cells from HFD-fed mice (Supplementary Fig. 4). This shift was also noted in 
MFehi ATMs. Flow analysis indicated a decrease in MGL1/2 and CD206 expression in obese 
MFehi ATMs (Fig. 5A and B) and a significant increase in the proportion of MFehi ATMs 
expressing CD11c and CCR2 (Fig. 5C and D). 
 
Figure 4. MFehi ATMs do not accumulate in obesity but do transition toward an inflammatory M1 
polarization. A and B: The number of MFelo ATMs are increased on an absolute basis (A) and relative to 
epididymal fat pad mass (B) in HFD compared with LFD mice (n = 9/group) (P < 0.05 for groups not 
connected by the same letter). C: The increase in MFelo ATMs in HFD mice leads to a reduction in the 
number of MFehi ATMs as a percent of total ATMs (n = 9/group) (***P < 0.001). D: MFehi ATM 
phenotype shifts toward an inflammatory M1 polarization in obesity. After sequential magnetic and 
FACS sorting, mRNA expression of M2 and M1 markers by MFehi ATMs isolated from LFD and HFD 
mice was analyzed via real-time RT-PCR (n = 4–7/group). *P < 0.05, ***P < 0.001, ****P < 0.0001. 
 
Figure 5. Obesity induces an inflammatory shift in MFehi ATM polarization.A: MFehi ATM expression of 
M2 markers, MGL1/2 (left panel) and CD206 (right panel), is reduced in obesity. M2 marker expression 
by viable F4/80hiCD11bhi, MFehiATMs was measured by flow cytometry. Isotype controls, HFD 
MFehi ATMs, and LFD MFehiATMs are represented by black, gray, and white histograms, 
respectively. B: Quantification and comparison of MGL1/2 (left panel) and CD206 (right panel) 
expression by LFD and HFD MFehi ATMs (n = 3/group for each marker) (*P < 0.05). C: Obesity 
increases the proportion of MFehi ATMs expressing the M1 markers CD11c (top row) and CCR2 (bottom 
row). M1 marker expression by viable F4/80hiCD11bhi, MFehi ATMs was measured by flow cytometry. 
Representative FACS plots of isotype controls, LFD MFehi ATMs, and HFD MFehi ATMs are shown in 
the left, middle, andright columns, respectively. D: Quantification and comparison of the number of 
CD11c+ (top panel) and CCR2+ (bottom panel) MFehi ATMs as a percent of total viable F4/80hiCD11bhi, 
MFehi ATMs in LFD and HFD mice (n = 3/group for each marker). *P < 0.05, **P < 0.01, ***P< 0.001. 
(A high-quality color representation of this figure is available in the online issue.) 
Obesity Impairs MFehi Iron Handling 
The inflammatory shift observed by MFehi ATMs after HFD was associated with a significant 
reduction in iron content (Fig. 6A). This effect was restricted to MFehi ATMs, as high-fat feeding 
did not significantly influence MFelo ATM iron content. Interestingly, the inclusion of ATM iron 
data from NCD mice in our analysis revealed that MFehi ATMs from NCD and LFD mice 
possess similar iron content, as do MFelo ATMs from all three groups (Supplementary Fig. 5A). 
The impairment in MFehi ATM iron handling after HFD was apparent at the transcriptional level 
as well. High-fat feeding resulted in decreased MFehi ATM expression of genes involved in iron 
uptake, metabolism, storage, and export (Fig. 6B). Obesity produced similar relative changes in 
the expression of iron-handling genes by MFelo ATMs (Supplementary Fig. 3A). 
 
Figure 6. Obesity impairs MFehi iron handling. A: Comparison of MFeloand MFehi ATM iron content 
from LFD and HFD mice. MFelo and MFehi ATMs were isolated via sequential magnetic and FACS 
sorting, and cellular iron content was quantified by ICP-MS (n = 5–6/group) (*P < 0.05 for groups not 
connected by the same letter). B: Obesity reduces MFehiATM iron metabolism gene expression. 
MFehi ATMs were isolated from LFD and HFD mice and analyzed by real-time RT-PCR for the 
expression of genes involved in iron metabolism (n = 5–7/group) (*P < 0.05, **P < 0.01, ***P < 0.001, 
****P < 0.0001). C: PPMs were cultured with 500 μmol/L palmitic acid (16:0) or oleic acid (18:1) for 24 
h. RNA was isolated, and gene expression for Tnfα, Il6, Clec10a, Cd163, Ftl1, Fth1, andHmox1 was 
performed. In addition, Western blotting for hemoxygenase-1 was performed. Data are presented as the 
mean ± SEM for 4–6 samples per group. *P < 0.05, **P < 0.01, ***P < 0.001. 
For determination of a potential mechanism by which obesity alters macrophage iron handling, 
mouse PPMs were treated with 500 μmol/L palmitate or oleate (Fig. 6C). As expected, palmitate 
increased inflammatory genes such as Tnfα and Il6, while oleate increased M2 markers such 
as Clec10a and Cd163. Interestingly, expression of Ftl1 andFth1 and the protein levels of 
hemoxygenase-1 were reduced in palmitate- but not oleate-treated PPMs. Expression 
of Slc40a1 was not altered by treatment with either fatty acid (data not shown). These studies 
indicate that saturated fatty acids released from IR adipocytes in obesity may contribute to the 
impaired macrophage iron handling observed during HFD feeding. 
Macrophages Recruited During HFD Feeding Are MFelo 
The identical number of MFehi ATMs relative to AT mass observed in LFD- and HFD-fed mice 
suggests that recruited macrophages do not take on a role in iron metabolism. To test this 
hypothesis, PKH26 labeling studies were performed. Mice were fed HFD for 6 weeks and then 
injected with PKH26 to label preexisting ATMs. One week after injection, the SVF was 
collected and sorted to isolate F4/80+PKH+ (pre-existing) and F4/80+PKH− (newly recruited) 
ATMs. Subsequently, magnetic sorting was used to quantify the proportion of MFehi and 
MFelo ATMs in each fraction (Fig. 7). Of the total cells counted, 60% were PKH+MFelo and 13% 
were PKH+MFehi, indicating that both MFelo and MFehi cells labeled with PKH were retained in 
the AT. Newly recruited PKH−MFelo cells made up 26% of the total ATMs. In contrast, only 
0.2% of the PKH− cells were MFehi, indicating that recruited macrophages do not take on an 
MFehi phenotype. 
 
Figure 7. ATMs recruited during HFD feeding are MFelo. Mice were fed an HFD for 6 weeks and then 
injected with PKH26 to label preexisting ATMs. Mice were maintained on the HFD for an additional 
week so that circulating monocytes could be recruited to the AT. Mice were killed, and the SVF was 
collected by collagenase digestion. ATMs were collected by FACS for F4/80 and were separated as either 
PHKpos (preexisting) or PKHneg (newly recruited). MFelo and MFehi cells were then isolated by magnetic 
sorting and counted. Data are presented as the percent of live cells. Almost no PKH− MFehi cells were 
detected, indicating that newly recruited cells do not immediately take on a role in iron metabolism. Data 
are presented as the mean ± SEM for 7 samples per group. ****P < 0.0001. 
Impaired MFehi Iron Handling Coincides With Adipocyte Iron Accumulation and Hepatic 
Iron Deficiency in Obesity 
Despite the reduction in MFehi ATM iron content after HFD feeding, staining for tissue iron 
accumulation via perfusion Perls’ Prussian blue indicated that whole AT iron concentrations 
were increased in obesity (Fig. 8A). Interestingly, HFD feeding produced a fourfold increase in 
adipocyte iron concentration (Fig. 8B), as well as a gene expression profile consistent with iron 
accumulation (Fig. 8C). In addition to iron accumulation, adipocytes isolated from obese AT 
displayed an inflammatory shift in gene expression, including decreased Adipoqexpression, 
upregulation of Il6, and a trend for increased Tnfα expression (Fig. 8D). 
 
Figure 8. Obesity induces tissue iron repartitioning. A: Visual comparison of epididymal fat pad iron 
content between LFD and HFD mice. Mice were perfused with Perls’ Prussian blue staining solution, and 
tissues were removed 1 h postperfusion. B: Comparison of adipocyte iron concentrations between LFD 
and HFD mice. Adipocytes were isolated from the epididymal fat pads of LFD and HFD mice via 
collagenase digestion. Adipocyte iron content was quantified by atomic absorption spectrometry and 
expressed relative to total protein (n = 6–7/group) (***P < 0.001). Cand D: Comparison of adipocyte 
gene expression from LFD and HFD mice. Real-time RT-PCR was used to assess adipocyte mRNA 
expression of genes involved in cellular iron metabolism (C) and Adipoq(adiponectin) and inflammatory 
cytokines (D). E: Visual comparison of hepatic iron content between LFD and HFD mice. Comparably 
sized pieces of the left lobe are presented. F: Comparison of hepatic iron concentrations between LFD 
and HFD mice. Liver iron content was quantified via atomic absorption spectrometry and expressed 
relative to total protein (n = 5/group) (*P < 0.05). G and H: Comparison of liver gene expression from 
LFD and HFD mice. Real-time RT-PCR was used to assess hepatic mRNA expression of genes involved 
in cellular (G) and systemic (H) iron metabolism (n = 4–7/group). *P < 0.05, **P< 0.01, ***P < 0.001, 
****P < 0.0001. 
Importantly, our finding of adipocyte iron overload in obesity was not indicative of a global 
increase in tissue iron stores, as Perls’ Prussian blue staining and quantification of liver iron 
concentrations revealed a >50% reduction in obese mice compared with lean controls (Fig. 
8E and F). Interestingly, this change in liver iron status did not elicit significant changes in the 
expression of genes associated with cellular iron handling (Fig. 8G); however, obesity reduced 
the expression of a specific cluster of genes important to the regulation of systemic iron 
homeostasis, includingTrfr2 (transferrin receptor 2), Bmp6 (bone morphogenic protein 
6),Tmprss6 (transmembrane protease, serine 6), and Hamp1 (hepcidin) (Fig. 8H). In contrast to 
the changes observed in hepatic and adipocyte iron concentrations, splenic iron concentrations 
were not significantly altered in obese mice, further pointing to a selective repartitioning of 
tissue iron stores in obesity (Supplementary Fig. 5B and C). 
With regard to circulating iron parameters, serum iron concentrations were not influenced by 
obesity (Supplementary Table 1). In contrast, serum transferrin was significantly elevated 
following high-fat feeding, which is consistent with the hepatic iron deficiency observed in obese 
mice. Circulating ferritin concentrations were likewise increased in obese mice. 
Discussion 
The past decade has witnessed a dramatic increase in our understanding and appreciation of the 
manner in which ATMs contribute to the metabolic consequences of obesity. Although the 
primary emphasis of the current literature lies with the contribution of ATMs to AT 
inflammation and IR, various studies have directly implicated ATMs in a number of homeostatic 
roles, including lipolysis (24), AT development (25), and remodeling (26). The current study 
demonstrates that resident ATMs are also involved in iron metabolism and lays the foundation 
for future investigations regarding a role for ATM iron handling in AT homeostasis, as well as 
the contribution of dysregulated ATM iron metabolism to AT function in obesity. 
In light of the epidemiological evidence linking hyperferritinemia with obesity and related 
comorbidities (27), several studies have focused on the effects of altered iron metabolism on AT 
function (10,28) and the possibility that AT may play an active role in regulating systemic iron 
homeostasis (29,30). However, the potential contribution of ATMs to AT iron metabolism remains 
an unexplored area of investigation. The current study provides the first evidence that ATMs 
play a role in local AT iron metabolism and highlights the significant heterogeneity that exists 
with respect to an ATM iron-handling phenotype. Specifically, that obesity induces a selective 
decrease in MFehi ATM iron content and that infiltrating ATMs do not accumulate iron suggest 
that iron handling within AT is restricted to a discrete population of resident alternatively 
activated MFehi ATMs. Importantly, this paradigm is not without precedence, as splenic (i.e., red 
pulp, marginal zone, and metallophillic macrophages) and atherosclerotic plaque macrophage 
populations present similarly divergent roles regarding iron metabolism (31,32). 
Recent studies describing the in vitro influence of polarization on macrophage iron handling 
suggest that M2 polarization induces an iron-recycling phenotype characterized by 
elevated Tfrc, Cd163, Hmox1, andFpn expression and an increased capacity for iron uptake and 
release (15,16). In contrast, M1 polarization elicits an iron sequestration phenotype. Our in vivo 
data agree with this model insofar as MFehi ATMs present an iron-recycling gene expression 
profile (i.e., upregulation of iron importers and the exporter, ferroportin) and elevated expression 
of M2 markers. However, important differences exist with respect to MFehi ATM phenotype and 
the published in vitro model of M1/M2 macrophage polarization and iron metabolism (15,16). The 
in vitro model suggests that M2 polarized macrophages have a reduced capacity for iron storage 
and that M1 macrophages display an iron sequestration phenotype with an associated increase in 
ferritin heavy-chain expression. This stands in stark contrast to our finding of elevated iron 
content in alternatively activated MFehi ATMs. Likewise, based on the published model, one 
would predict that inflammation would lead to iron sequestration by M1 ATMs. On the contrary, 
our in vivo data suggest that obesity-associated inflammation does not increase recruited M1 
ATM iron stores; rather, we observed a selective decrease in the iron content of MFehi ATMs 
coinciding with a shift toward an inflammatory phenotype. Furthermore, our studies demonstrate 
that treatment of macrophages with saturated fatty acids reduced genes and proteins associated 
with iron storage. Thus, it is possible that macrophage inflammation induced by fatty acids 
invokes different effects on iron metabolism compared with M1 polarization via traditional 
methods. Although the above discrepancies do not necessarily preclude the possibility that 
MFehi ATMs represent a subset of M2-polarized macrophages (i.e., M2a, -b, or -c) (33), the 
phenotype of MFehiATMs more closely aligns with the recently characterized Mhem polarization 
state (31). Mhem macrophages are a discrete population of atheroprotective macrophages induced 
after intraplaque hemorrhage and the resultant heme exposure. Similar to MFehi ATMs, Mhem 
macrophages display elevated iron content and increased expression of Cd163, Hmox-1, and Il-
10. Interestingly, the Mhem program is driven by heme-induced activating transcription factor-1 
phosphorylation. Further research will be necessary to determine whether the observed 
MFehi phenotype is similarly regulated. 
Results of the current study raise a number of important questions regarding the physiological 
relevance of ATM iron metabolism to AT function as well as the mechanism(s) underlying 
impaired MFehi ATM iron handling in obesity. Adequate control of iron availability appears 
crucial to AT homeostasis. Previous in vitro studies have demonstrated that heme-associated iron 
induces preadipocyte differentiation and is required to support adipogenesis (4,5). In contrast to its 
role in supporting adipogenesis, in vitro iron treatment induces lipolysis and IR in mature 
adipocytes (7,34). Furthermore, Gabrielsen et al. (6) recently used an elegant series of dietary and 
genetic manipulations to induce adipocyte iron overload and demonstrated that adipocyte iron 
regulates adiponectin expression and systemic glucose homeostasis. In agreement, we observed a 
significant decrease in adipocyte Adipoq gene expression after obesity-induced adipocyte iron 
accumulation. Interestingly, the occurrence of adipocyte iron overload in our study coincided 
with a reduction in MFehiATM iron content and iron-recycling gene expression. In light of our 
findings and the available literature regarding AT iron metabolism, we propose a working model 
whereby resident MFehi ATMs fulfill the dual roles of providing an adequate supply of iron to 
support adipogenesis, analogous to macrophages acting as a source of iron for proliferating 
lymphocytes in the lymph nodes (35), and protecting adipocytes from oxidative stress by 
scavenging extracellular heme. Thus, impaired MFehi ATM iron handling in the setting of 
hyperinsulinemia, which induces adipocyte iron uptake (36,37), may play a role in the development 
of AT dysfunction in obesity. Future experiments are required to determine the role of resident 
ATM iron metabolism in AT homeostasis. 
An intriguing aspect of the current study includes the observation of tissue iron repartitioning in 
obesity, which occurred in the absence of changes in serum iron concentrations. Specifically, 
hepatic iron concentrations were significantly decreased, whereas adipocyte iron concentrations 
were increased. Our finding of reduced hepatic iron stores and hepcidin expression is in line with 
previous studies in rodent models of obesity (38–40). Although our in vivo studies were not 
designed to address the underlying mechanism(s) responsible for changes in iron distribution, 
our data point to a potentially important interaction between iron and lipid metabolism. After 16 
weeks of HFD, WT mice display visceral lipoatrophy accompanied by a dramatic increase in 
liver lipid accumulation (41). Likewise, high-fat feeding has been shown to induce ATM lipid 
accumulation (42). Interestingly, our data suggest that ectopic lipid accumulation in obesity is 
accompanied by a shift in tissue iron distribution, such that adipocytes display iron 
concentrations equivalent to the liver. Thus, sites crucial to the maintenance of systemic iron 
homeostasis (i.e., liver and macrophages) experience lipid accumulation coincident with a 
relative state of iron deficiency. Conversely, dysregulated lipolysis and atrophy of the AT are 
accompanied by adipocyte iron overload. 
Increasing evidence points to important yet complex associations among adiposity, IR, and iron 
metabolism. The potential contribution of AT to systemic iron homeostasis has received 
increased attention recently; however, the role of ATMs in AT iron metabolism remains 
unexplored. The current study describes a novel population of alternatively activated 
MFehiATMs that displays elevated cellular iron content along with an anti-inflammatory and 
iron-recycling gene expression profile. Importantly, the impairment of MFehi ATM iron handling 
is temporally associated with adipocyte iron overload and AT dysfunction in obesity. 
Additionally, our data provide the first evidence that diet-induced obesity leads to a 
repartitioning of tissue iron stores and argue for a coordinated regulation of lipid and iron 
metabolism. Collectively, our data lay the foundation for future investigations regarding the role 
of ATM iron handling in AT homeostasis and the mechanisms underlying the development of 
impaired iron metabolism in obesity. 
Article Information 
Funding. This project was supported by a Discovery Grant in Innovative Diabetes Research 
from the Vanderbilt Diabetes Center (DK-20593) and National Institutes of Health (NIH) R21 
DK-095456. The authors were supported by the following grants: NIH Ruth L. Kirschstein 
NRSA F32 DK-091040 (to J.S.O.), American Diabetes Association Mentor–based Postdoctoral 
Fellowship 7-10-MI-05 (to A.K.), American Heart Association Pre-doctoral Fellowship 
12PRE11910047 (to E.K.A.-B.), NIH R21 DK-095456 (to C.D.W. and A.H.H.), and American 
Heart Association Established Investigator Award 12EIA8270000 (to A.H.H.). Flow cytometry 
was performed through Vanderbilt University Medical Center (VUMC) Digestive Disease 
Research Center supported by NIH DK-058404 Core Scholarship. Cellular iron measurements 
were performed by the VUMC Mass Spectrometry Research Core (supported by NIH Shared 
Instrumentation grant S10 RR-026742). Immunofluorescence imaging was conducted in part 
through the use of the VUMC Cell Imaging Shared Resource (supported by NIH grants CA-
68485, DK-20593, DK-58404, HD-15052, DK-59637, and EY-08126). Serum iron parameter 
measurements were performed by the Vanderbilt Translational Pathology Shared Resource 
(supported by DK-059637). 
Duality of Interest. S.K.M. is a minority shareholder of Cytoguide ApS (Aarhus, Denmark). 
The rat anti-mouse CD163 monoclonal antibody (E10B10) was a kind gift from Cytoguide ApS. 
No other potential conflicts of interest relevant to this article were reported. 
Author Contributions. J.S.O. collected and analyzed data and wrote the manuscript. A.K., 
E.K.A.-B., C.D.W., S.C.F., K.M.E., Y.Z., A.E., and S.K.M. helped collect data and edit the 
manuscript. A.H.H. obtained funding, aided with data analysis, and edited the manuscript. 
A.H.H. is the guarantor of this work and, as such, had full access to all the data in the study and 
takes responsibility for the integrity of the data and the accuracy of the data analysis. 
Footnotes 
• This article contains Supplementary Data online a 
thttp://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db13-0213/-/DC1. 
• Received February 6, 2013. 
• Accepted October 8, 2013. 
• © 2014 by the American Diabetes Association. 
Readers may use this article as long as the work is properly cited, the use is educational and not 
for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for 
details. 
 References 
1. Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin 
Invest 2011;121:2094–2101 
2. Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the metabolic 
syndrome--an allostatic perspective. Biochim Biophys Acta 2010;1801:338–349  
3. Festa M, Ricciardelli G, Mele G, Pietropaolo C, Ruffo A, Colonna A.Overexpression of H 
ferritin and up-regulation of iron regulatory protein genes during differentiation of 3T3-L1 
pre-adipocytes. J Biol Chem 2000;275:36708–36712 
4. Chen JJ, London IM. Hemin enhances the differentiation of mouse 3T3 cells to 
adipocytes. Cell 1981;26:117–122 
5. Kumar N, Solt LA, Wang Y, et al. Regulation of adipogenesis by natural and synthetic REV-
ERB ligands. Endocrinology2010;151:3015–3025 
6. Gabrielsen JS, Gao Y, Simcox JA, et al. Adipocyte iron regulates adiponectin and insulin 
sensitivity. J Clin Invest 2012;122:3529–3540 
7. Green A, Basile R, Rumberger JM. Transferrin and iron induce insulin resistance of glucose 
transport in adipocytes. Metabolism2006;55:1042–1045 
8. Cooksey RC, Jones D, Gabrielsen S, et al. Dietary iron restriction or iron chelation protects 
from diabetes and loss of beta-cell function in the obese (ob/ob lep-/-) mouse. Am J Physiol 
Endocrinol Metab2010;298:E1236–E1243 
9. Minamiyama Y, Takemura S, Kodai S, et al. Iron restriction improves type 2 diabetes 
mellitus in Otsuka Long-Evans Tokushima fatty rats.Am J Physiol Endocrinol 
Metab 2010;298:E1140–E1149 
10. Tajima S, Ikeda Y, Sawada K, et al. Iron reduction by deferoxamine leads to amelioration of 
adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes 
KKAy mice. Am J Physiol Endocrinol Metab 2012;302:E77–E86 
11. Valenti L, Fracanzani AL, Dongiovanni P, et al. Iron depletion by phlebotomy improves 
insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: 
evidence from a case-control study. Am J Gastroenterol 2007;102:1251–1258 
12. Valenti L, Moscatiello S, Vanni E, et al. Venesection for non-alcoholic fatty liver disease 
unresponsive to lifestyle counseling--a propensity score-adjusted observational study. QJM 
2011;104:141–149  
13. Fernández-Real JM, Peñarroja G, Castro A, García-Bragado F, Hernández-
Aguado I, Ricart W. Blood letting in high-ferritin type 2 diabetes: effects on insulin 
sensitivity and beta-cell function.Diabetes 2002;51:1000–1004 
14. Ganz T. Macrophages and systemic iron homeostasis. J Innate Immun 2012;4:446–453 
15. Corna G, Campana L, Pignatti E, et al. Polarization dictates iron handling by inflammatory 
and alternatively activated macrophages.Haematologica 2010;95:1814–1822 
16. Recalcati S, Locati M, Marini A, et al. Differential regulation of iron homeostasis during 
human macrophage polarized activation. Eur J Immunol 2010;40:824–835 
17. Orr JS, Puglisi MJ, Ellacott KL, Lumeng CN, Wasserman DH,Hasty AH. Toll-like receptor 4 
deficiency promotes the alternative activation of adipose tissue 
macrophages. Diabetes2012;61:2718–2727 
18. Orr JS, Kennedy AJ, Hasty AH. Isolation of adipose tissue immune cells. J Vis Exp. 22 May 
2013 [Epub ahead of print] 
19. Kotecha N, Krutzik PO, Irish JM. Web-based analysis and publication of flow cytometry 
experiments. Curr Protoc Cytom 2010;Chapter 10;Unit10.17  
20. Anderson EK, Hill AA, Hasty AH. Stearic acid accumulation in macrophages induces toll-
like receptor 4/2-independent inflammation leading to endoplasmic reticulum stress-mediated 
apoptosis.Arterioscler Thromb Vasc Biol 2012;32:1687–1695 
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time 
quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402–408 
22. Asano Y, Meguro R, Odagiri S, Li C, Iwatsuki H, Shoumura K.Visualization of non-heme 
ferric and ferrous iron by highly sensitive non-heme iron histochemistry in the stress-induced 
acute gastric lesions in the rat. Histochem Cell Biol 2006;125:515–525 
23. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue 
macrophage polarization. J Clin Invest2007;117:175–184 
24. Nguyen KD, Qiu Y, Cui X, et al. Alternatively activated macrophages produce 
catecholamines to sustain adaptive thermogenesis. Nature 2011;480:104–108 
25. Han J, Lee JE, Jin J, et al. The spatiotemporal development of adipose 
tissue. Development 2011;138:5027–5037 
26. Cho CH, Koh YJ, Han J, et al. Angiogenic role of LYVE-1-positive macrophages in adipose 
tissue. Circ Res 2007;100:e47–e57 
27. Zafon C, Lecube A, Simo R. Iron in obesity. An ancient micronutrient for a modern disease. 
Obes Rev 2010;11:322–328 
28. Burgess A, Li M, Vanella L, et al. Adipocyte heme oxygenase-1 induction attenuates 
metabolic syndrome in both male and female obese mice. Hypertension 2010;56:1124–1130 
29. Bekri S, Gual P, Anty R, et al. Increased adipose tissue expression of hepcidin in severe 
obesity is independent from diabetes and NASH.Gastroenterology 2006;131:788–796 
30. Luciani N, Brasse-Lagnel C, Poli M, et al. Hemojuvelin: a new link between obesity and iron 
homeostasis. Obesity (Silver Spring)2011;19:1545–1551 
31. Boyle JJ, Johns M, Kampfer T, et al. Activating transcription factor 1 directs Mhem 
atheroprotective macrophages through coordinated iron handling and foam cell 
protection. Circ Res 2012;110:20–33 
32. Kohyama M, Ise W, Edelson BT, et al. Role for Spi-C in the development of red pulp 
macrophages and splenic iron homeostasis.Nature 2009;457:318–321 
33. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M.The chemokine system in 
diverse forms of macrophage activation and polarization. Trends Immunol 2004;25:677–686 
34. Rumberger JM, Peters T Jr., Burrington C, Green A. Transferrin and iron contribute to the 
lipolytic effect of serum in isolated adipocytes.Diabetes 2004;53:2535–2541 
35. Djeha A, Pérez-Arellano JL, Brock JH. Transferrin synthesis by mouse lymph node and 
peritoneal macrophages: iron content and effect on lymphocyte 
proliferation. Blood 1993;81:1046–1050 
36. Davis RJ, Corvera S, Czech MP. Insulin stimulates cellular iron uptake and causes the 
redistribution of intracellular transferrin receptors to the plasma membrane. J Biol 
Chem1986;261:8708–8711 
37. Tanner LI, Lienhard GE. Insulin elicits a redistribution of transferrin receptors in 3T3-L1 
adipocytes through an increase in the rate constant for receptor externalization. J Biol 
Chem1987;262:8975–8980 
38. Chung J, Kim MS, Han SN. Diet-induced obesity leads to decreased hepatic iron storage in 
mice. Nutr Res 2011;31:915–921 
39. Le Guenno G, Chanséaume E, Ruivard M, Morio B, Mazur A. Study of iron metabolism 
disturbances in an animal model of insulin resistance.Diabetes Res Clin Pract 2007;77:363–
370 
40. Sonnweber T, Ress C, Nairz M, et al. High-fat diet causes iron deficiency via hepcidin-
independent reduction of duodenal iron absorption. J Nutr Biochem 2012;23:1600–1608 
41. Strissel KJ, Stancheva Z, Miyoshi H, et al. Adipocyte death, adipose tissue remodeling, and 
obesity complications. Diabetes2007;56:2910–2918 
42. Prieur X, Mok CY, Velagapudi VR, et al. Differential lipid partitioning between adipocytes 
and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese 
mice. Diabetes2011;60:797–809 
  
 
